• Dollar index falls for the third day, US indices opened higher
• UnitedHealth (UNH.US) share price rose as company pushes self-collected coroanvirus test
Despite the disappointing macroeconomic data the US indices opened higher in another volatile session as investors were already pricing in an increase in number of unemployed in the near future as the impact of the spreading pandemic remains uncertain. Market sentiment was improved by the statement of treasury secretary Steven Mnuchin, who announced that ch US citizens should receive checks within three weeks.
S&P500 (US500) - despite bad data from the US labor market, the index still trades around significant support levels at 2505 pts. In case we see a break above this level, then S&p500 may be set to test the next major resistance at 2722.6 pts. Source:xStation5.FactSet (FDS.US) – The financial-information services provider reported better than expected quarterly earnings of $2.55 per share. These figure beats forcasts by 6 cents a share. Revenue was slightly lower than expected. The company also announced that will not update any financial guidance until its next quarterly results.
FactSet (FDS.US)- bounced off the support at $229.32 per share and is currently testing key support at $237.70 per share. If the price manages to close above this level, then the upward movement may continue towards next resistance at $253.51 per share.. Source: xStation5.UnitedHealth (UNH.US) – The health-services company is introducing a new self-administer coronavirus test which could reduce the risk to health-care workers. The test calls for patients to swab their noses, drop the swab into test tubes, and hand the tubes back to the health-care workers. Company advised that the Food and Drug Administration (FDA) has updated its guidance on self-administered testing to allow the nationwide use of self-administered tests.
UnitedHealth (UNH.US) – is enjoying a strong run higher as investors hope its new tests will show effects in fighting coronavirus.. Stock reached major resistance level at $240.25 per share. If the bearish bias continues then stock may be heading for next target at around $267.80 per share. Support is located at $210.94 per share. Source:xStation5.The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
